James Errey, Of Heptares To Talk At Protein Expression Meeting, Oct 23-24, 2014, Boston, MA
James C. Errey, Associate Director at Heptares Therapeutics Limited to Give a Presentation titled, "From StaR® to Structure, it's as easy as ABC" at the Protein Expression, Purification & Characterization Conference, October 23 & 24, 2014, in Boston, MA.
- (1888PressRelease) May 31, 2014 - Dr Errey has an MSc in Biotechnology from the University of Kent (1999) and a Ph.D. in carbohydrate biochemistry from the University of East Anglia (2003) under the supervision of Professor Rob Field. He then went on to spend three years as a postdoctoral fellow in the laboratory of Professor John Blanchard at Albert Einstein College of Medicine New York studying the enzymology of mycobacterial proteins. In 2006 he returned to the U.K. as a postdoctoral fellow in the laboratory of Professor Ben Davis at Oxford University, exploring new methods for the selective post-translational modification of proteins.
In 2008 he joined Heptares Therapeutics Ltd, a GPCR drug discovery company utilizing a novel structure-based drug discovery approach exploiting stabilized receptors (StaRs®). Since starting at Heptares he has helped setup their protein biochemistry group leading to the structural determination of a number of therapeutically relevant GPCRs.
For more information, please visit www.GTCbio.com/antibodyprotein.
###
space
space
Satisfied Users & 
Approved Press Releases
Print
Email
Report Spam